Research Article

Comprehensive Analysis of Potential Biomarkers of Acute Lymphoblastic Leukemia in Children by Using a Competing Endogenous RNA Network

Table 1

Clinical characteristics of 261 patients with pediatric ALL.

Low risk ()High risk () valueOverall ()

Age (years)
 Mean (SD)8.11 (5.40)7.63 (5.02)0.4747.94 (5.26)
 Median [min, max]6.88 [0.918, 30.0]6.50 [0.0329, 16.2]6.61 [0.0329, 30.0]
Gender
 Female85 (50.3%)43 (46.7%)0.675128 (49.0%)
 Male84 (49.7%)49 (53.3%)133 (51.0%)
White blood cell count
 <50169 (100%)0 (0%)<0.001169 (64.8%)
 ≥500 (0%)92 (100%)92 (35.2%)
BCR-ABL1 fusion
 Yes0 (0%)5 (5.4%)0.009675 (1.9%)
 No169 (100%)87 (94.6%)256 (98.1%)
ETV6-RUNX1 fusion
 Yes19 (11.2%)2 (2.2%)0.019521 (8.0%)
 No150 (88.8%)90 (97.8%)240 (92.0%)
TCF3_HLF
 Yes15 (8.9%)7 (7.6%)0.90522 (8.4%)
 No154 (91.1%)85 (92.4%)239 (91.6%)
Trisomy of both chromosomes 4 and 10
 Yes14 (8.3%)7 (7.6%)121 (8.0%)
 No155 (91.7%)85 (92.4%)240 (92.0%)
TCF3PBX1
 Yes15 (8.9%)7 (7.6%)0.90522 (8.4%)
 No154 (91.1%)85 (92.4%)239 (91.6%)
Overall survival time (year)
 Mean (SD)4.70 (3.26)4.94 (3.70)0.64.78 (3.41)
 Median [min, max]3.33 [0.271, 14.5]3.21 [0.0685, 12.0]3.33 [0.0685, 14.5]
 Missing1 (0.6%)3 (3.3%)4 (1.5%)
Event free survival time (years)
 Mean(SD)2.80 (2.19)4.05 (3.76)0.004753.24 (2.89)
 Median [min, max]2.38 [0.211, 11.2]2.54 [0.0685, 12.0]2.39 [0.0685, 12.0]
 Missing4 (2.4%)3 (3.3%)7 (2.7%)